President, CEO of Chinook Therapeutics, Inc. (NASDAQ:KDNY), Dobmeier Eric, buys 500 shares worth $6,750
According to Chinook Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 07:26 PM, company President, CEO, Dobmeier Eric disclosed buying 500 shares at a cost of $13.50. At the time of this transaction (Nov 19), this trade was worth $6,750 in total. As of Nov 19, Dobmeier Eric now owns 51,337 shares in total worth about $699,723.31.
For the last few recent trades made by Chinook Therapeutics, Inc. (NASDAQ:KDNY) President, CEO, Dobmeier Eric, we have the following information:
- SEC Form 4 filing: Nov 20: Bought 571 shares at the rate of $13.69 per share. Total worth of this trade was $7,817. Total number of shares owned as of Nov 20 were 51,908
- SEC Form 4 filing: Nov 23: Bought 929 shares at the rate of $13.67 per share. Total worth of this trade was $12,699. Total number of shares owned as of Nov 23 were 52,837
- SEC Form 4 filing: Nov 10: Bought 2,000 shares at the rate of $13.86 per share. Total worth of this trade was $27,720. Total number of shares owned as of Nov 10 were 48,337
Posted by
George Daniels
on Tuesday November 24 2020, 12:14 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
